APTORUM GROUP
Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) is a pharmaceutical company dedicated to the discovery, development and commercializing of therapeutic assets to treat diseases with unmet medical needs, particularly infectious diseases and cancers (including orphan oncology indications). The pipeline of Aptorum is also enriched through the establishment of drug discovery platforms that enable the discovery of new therapeutics assets through, e.g. systematic screening of existing approved... drug molecules, and microbiome-based research platform for treatments of metabolic diseases. In addition to the above main focus, it is also pursuing therapeutic and diagnostic projects in neurology, gastroenterology, metabolic disorders, women’s health and other disease areas. It also has projects focused on surgical robotics and natural supplement for women undergoing menopause and experiencing related symptoms.
APTORUM GROUP
Social Links:
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2010-01-01
Address:
London, England, United Kingdom
Country:
United Kingdom
Website Url:
http://www.aptorumgroup.com
Total Employee:
11+
Status:
Active
Contact:
+44 20 80929299
Email Addresses:
[email protected]
Total Funding:
23.6 M USD
Technology used in webpage:
IPv6 Akamai Hosted Hong Kong Server Location Bing Maps
Similar Organizations
Adamas Pharmaceuticals
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals is a biotechnology company that focuses on the development of medicine to treat diseases with a genetic origin.
Aura Biosciences
Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
Recro Pharma
Recro Pharma is a pharmaceutical company developing non-opioid therapeutics for the treatment of pain.
Current Employees Featured
Founder
Stock Details
Investors List
Aenco Technologies
Aenco Technologies investment in Post-IPO Debt - Aptorum Group
Official Site Inspections
http://www.aptorumgroup.com Semrush global rank: 7.25 M Semrush visits lastest month: 840
- Host name: chrysolite.uhost.hk
- IP address: 103.11.228.160
- Location: Hong Kong
- Latitude: 22.25
- Longitude: 114.1667
- Timezone: Asia/Hong_Kong
More informations about "Aptorum Group"
Aptorum Group - Crunchbase Company Profile
Contact Email [email protected] Phone Number +44 20 80929299 Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) is a pharmaceutical company dedicated to the discovery, development and …See details»
Aptorum Group - Overview, News & Similar companies - ZoomInfo
Dec 22, 2023 Aptorum Group contact info: Phone number: +44 2080929299 Website: www.aptorumgroup.com What does Aptorum Group do? Aptorum Group Limited (Nasdaq: …See details»
Aptorum Group Limited (Nasdaq: APM) | LinkedIn
Aptorum Group Limited (Nasdaq: APM) | 636 followers on LinkedIn. Facilitate life science innovations to tackle unmet medical needs. | At Aptorum, we believe that by facilitating the …See details»
Aptorum Group Ltd Announces Entering into an Agreement and …
NEW YORK & LONDON, March 06, 2024--Aptorum Group Limited (Nasdaq: APM), a clinical stage biopharmaceutical company ("Aptorum"), and privately-held YOOV Group Holding Ltd. …See details»
Aptorum Group - Craft
Oct 29, 2024 Aptorum Group has 5 employees across 7 locations and $431 k in annual revenue in FY 2023. See insights on Aptorum Group including office locations, competitors, revenue, …See details»
Aptorum Group Limited Reports 2021 Fiscal Year End Financial …
Apr 29, 2022 Investor Relations [email protected] +44 20 80929299 Redchip – Financial Communications United States Investor relations Dave Gentry …See details»
Aptorum Group Limited Announces Results of 2020 Annual …
Dec 9, 2020 [email protected] +44 20 80929299 Redchip – Financial Communications United States Investor Relations Dave Gentry [email protected] +1 407 …See details»
APTORUM (Nasdaq: APM) - aptorumgroup.com
Aptorum Group Limited (Nasdaq: APM) is a biopharmaceutical company dedicated to developing and commercializing novel therapeutics to tackle unmet medical needs.Aptorum Group is …See details»
APTORUM (Nasdaq: APM)
North America Office; Address: 1325 Avenue of the Americas, 27th and 28th Floors, New York, 10019, USA; Tel: +1 617 8929932 ; Email: [email protected]See details»
Aptorum Group Limited to Hold Annual General Meeting of …
Nov 8, 2022 Aptorum Group Limited Investor Relations Department [email protected] +44 20 80929299 Redchip – Financial Communications …See details»
Aptorum Group Limited Reports Financial Results and Business …
[email protected] +44 20 80929299 Redchip – Financial Communications United States Investor relations Dave Gentry [email protected] +1 407 491 4498 Actifin – …See details»
Aptorum Group Limited Reports 2020 Fiscal Year End Financial …
[email protected] +44 20 80929299 Redchip – Financial Communications United States Investor relations Dave Gentry [email protected] +1 407 491 4498 Actifin – …See details»
Aptorum Group Limited Interview to Air on Bloomberg U.S.
Oct 15, 2021 Contacts. Aptorum Group Limited Investor Relations Department [email protected] +44 20 80929299 Redchip – Financial Communications …See details»
Aptorum Group Limited Reports Financial Results and Business …
NEW YORK & LONDON, December 22, 2023--Aptorum Group Limited (NASDAQ: APM) ("Aptorum Group" or the "Company"), a clinical stage biopharmaceutical company dedicated …See details»
APTORUM (Nasdaq: APM)
Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) is a clinical stage biopharmaceutical company dedicated to the discovery, development and commercialization …See details»
APTORUM (Nasdaq: APM)
Professor Douglas W. Arner is an Independent Non-Executive Director of Aptorum Group Limited. Douglas is the Kerry Holdings Professor in Law and Director and co-founder of the Asian …See details»
Aptorum Group Limited Announces Results of 2023 Annual …
NEW YORK & LONDON, December 21, 2023--Aptorum Group Limited (Nasdaq: APM) ("Aptorum Group" or "Aptorum"), a clinical stage biopharmaceutical company dedicated to meeting …See details»
Aptorum Group Limited Reports Financial Results and Business …
Sep 30, 2022 Aptorum Group Limited Investor Relations Department [email protected] +44 20 80929299 Redchip – Financial Communications …See details»
Aptorum Group Announces the Launch of its Oncology and …
[email protected] +44 20 80929299 Redchip – Financial Communications United States Investor relations Dave Gentry [email protected] +1 407 491 4498 Actifin – …See details»
Amentum Appoints Darren Burton as Chief People Officer
1 day ago Amentum (NYSE: AMTM) today announced the appointment of Darren Burton as Chief People Officer, effective immediately. Burton will lead all aspects ofSee details»